作者:
Ellis,P.M. [1]
;
Shepherd,F.A. [2]
;
Millward,M. [3]
;
Perrone,F. [4]
;
Seymour,L. [5]
;
Liu,G. [6]
;
Sun,S. [7]
;
Cho,B.C. [8]
;
Morabito,A. [9]
;
Leighl,N.B. [10]
;
Stockler,M.R. [11]
;
Lee,C.W. [12]
;
Wierzbicki,R. [13]
;
Cohen,V. [14]
;
Blais,N. [15]
;
Sangha,R.S. [16]
;
Favaretto,A.G. [17]
;
Kang,J.H. [18]
;
Tsao,M.-S. ;
Wilson,C.F. ;
Goldberg,Z. ;
Ding,K. ;
Goss,G.D. ;
Bradbury,P.A.
作者单位:
Centre Hospitalier de l'Université de MontréalMontreal, QC, Canada
[1]
Istituto Oncologico VenetoPadua, Italy
[2]
Seoul St Mary's Hospital, The Catholic UniversitySeoul, South Korea
[3]
Division of Medical Oncology, University of OttawaOttawa, ON, Canada
[4]
Cross Cancer InstituteEdmonton, AB, Canada
[5]
University of Western AustraliaPerth, WA, Australia, Australasian Lung Cancer Trials GroupSydney
[6]
British Columbia Cancer Agency, Vancouver CentreVancouver, BC, Canada
[7]
NCIC Clinical Trials Group, Queen's UniversityON, Canada
[8]
R S MacLaughlin Durham RegionalCancer CentreOshawa, ON, Canada
[9]
Jewish General Hospital and Segal Cancer Centre, McGill UniversityMontreal, QC, Canada
[10]
Thoraco-Pulmonary Medical Oncology, Istituto Nazionale Tumori Fondazione G Pascale-IRCCSNapoli
[11]
NHMRC Clinical Trials Centre, University of SydneySydney, NSW, Australia
[12]
British Columbia Cancer Agency, Fraser Valley CentreSurrey, BC, Canada
[13]
Pfizer OncologyLa Jolla, CA, United States
[14]
Clinical Trials Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori-Fondazione G Pascale
[15]
Juravinski Cancer CentreHamilton, ON, Canada
[16]
Yonsei Cancer Centre, Yonsei University College of MedicineSeoul, South Korea
[17]
Princess Margaret Cancer CentreToronto, ON, Canada
[18]
发布时间
2015-02-04